[Progesterone and preterm delivery: Back to the future?].

Abstract : Progesterone was widely used in France during the 1980s and 1990s to prevent preterm birth until some published cases of cholestasis suddenly stopped its prescription. Since then, multiple randomized controlled trials have emerged and demonstrated the efficiency of the treatment but also its safety at low doses. In order to clarify its indications, we performed a current literature review. We analyzed literature data according to different categories of risk and different routes of administration. Results confirm that progesterone is an efficient treatment to prevent preterm birth in singleton gestation with short cervical length, and in singleton gestation with prior preterm birth with or without short cervical length. Apart from these indications, progesterone, especially 17-alpha-hydroxyprogesterone (17OHP), should not be used outside research protocols.
Type de document :
Article dans une revue
Gynécologie Obstétrique et Fertilité, Elsevier Masson, 2014, 42 (2), pp.112-22. 〈10.1016/j.gyobfe.2013.12.006〉
Liste complète des métadonnées

Littérature citée [51 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00960303
Contributeur : Florent Fuchs <>
Soumis le : lundi 17 mars 2014 - 23:02:48
Dernière modification le : vendredi 17 février 2017 - 14:30:30
Document(s) archivé(s) le : lundi 10 avril 2017 - 01:06:01

Fichier

 Accès restreint
Fichier visible le : jamais

Connectez-vous pour demander l'accès au fichier

Identifiants

Collections

Citation

Florent Fuchs, François Audibert, Marie-Victoire Senat. [Progesterone and preterm delivery: Back to the future?].. Gynécologie Obstétrique et Fertilité, Elsevier Masson, 2014, 42 (2), pp.112-22. 〈10.1016/j.gyobfe.2013.12.006〉. 〈inserm-00960303〉

Partager

Métriques

Consultations de la notice

491